Glaucoma Drainage Device

NASHVILLE, Tenn. — Stand-alone microstent implantation and trabeculectomy are both effective at treating glaucoma, with the microstent possibly providing an alternative to trabeculectomy, according to a study presented here.

The KDB Glide, a device for advanced excisional goniotomy, is now commercially available in the U.S., New World Medical announced in a press release.

The FDA has registered New World Medical’s KDB Glide as a Class 1 device, which will soon be available in the U.S., according to a company press release.

The most popular glaucoma articles on Healio/OSN in September include a current look at MIGS, the use of a nonvalved aqueous drainage implant and an update on a phase 2 trial.

In this Healio Video Perspective, Dave Van Meter, CEO of Ivantis, discusses the global launch of the Hydrus microstent for the treatment of glaucoma, and the data accumulated with the device over more than 4 years.

In this Healio Video Perspective, Chris Calcaterra, chief operating officer at Glaukos Corp., discusses the company’s commitment to ophthalmologists and their patients throughout the coronavirus pandemic and going forward.